Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-04-29Clinical Trial Update: The Effect of BAT Versus Mixed Physical Activity as add-on Treatment for Traumatised Refugees. [Phase 3]
Phase 3 trial comparing BAT as an add-on therapy versus mixed physical activity for traumatised refugees with PTSD and depression; the study…
-
CLINICAL_TRIALS trial_result · 2016-04-29Clinical Trial Update: The Antidepressant Efficacy of the Anticholinergic Scopolamine [Phase 2]
A Phase 2 trial evaluated the antidepressant efficacy of scopolamine in unipolar and bipolar depression. The study was terminated and result…
-
CLINICAL_TRIALS research · 2016-04-29Clinical Trial Update: Family Psychoeducation for Major Depressive Disorder [NA]
This document provides an update on a clinical trial evaluating family psychoeducation as an intervention for major depressive disorder.
-
CLINICAL_TRIALS trial_result · 2016-04-26Clinical Trial Update: Web-based CBT for Symptoms of Mild-to-Moderate Anxiety and Depression in Youth With Chronic Illness [NA]
The study evaluated a web-based cognitive-behavioral therapy program for reducing anxiety and depression symptoms in youths with chronic ill…
-
FDA approval · 2016-04-25FDA Approved: WELLBUTRIN SR — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for WELLBUTRIN SR (bupropion hydrochloride) submitted by GlaxoSmithKline LLC. The action confirms th…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-04-25FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for amitriptyline hydrochloride by Aurobindo Pharma Limited.
-
FDA approval · 2016-04-25FDA Approved: PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE (Mylan Pharmaceuticals Inc.). This action updates t…
-
FDA approval · 2016-04-25FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Amitriptyline hydrochloride by Sandoz Inc, indicating approval of changes to the existing generi…
-
CLINICAL_TRIALS trial_result · 2016-04-22Clinical Trial Update: Social Connections and Healthy Aging (The Senior Connection) [Phase 2]
Phase 2 clinical trial evaluating the Senior Connection program for social engagement and healthy aging has completed, studying impacts on s…
-
CLINICAL_TRIALS trial_result · 2016-04-21Clinical Trial Update: LEPR Polymorphism Weight Gain by Mirtazapine in Late Life Depression [Phase 4]
This document provides a Phase 4 clinical trial update on weight gain associated with LEPR polymorphism in late-life depression treated with…
-
CLINICAL_TRIALS trial_result · 2016-04-21Clinical Trial Update: The Synchronized Trial on Expectant Mothers With Depressive Symptoms by Omega-3 PUFAs (SYNCHRO): Open Trial [Phase 2]
Phase 2 open trial SYNCHRO evaluating Omega-3 polyunsaturated fatty acids for depressive symptoms in pregnant individuals has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-21Clinical Trial Update: Combining Emotion Regulation and Mindfulness Skills for Preventing Depression Relapse [NA]
A completed clinical trial evaluating whether a combined emotion regulation and mindfulness skills program can prevent relapse in adults wit…
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: Prevention of Adolescent Major Depression [NA]
Clinical trial investigating prevention of adolescent major depressive disorder has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-04-19Clinical Trial Update: Trial of a Positive Psychology Intervention in Major Depressive Disorder [NA]
ClinicalTrials.gov shows a completed trial evaluating a positive psychology intervention for Major Depressive Disorder.
-
CLINICAL_TRIALS trial_result · 2016-04-18Clinical Trial Update: Mecamylamine for the Treatment of Patients With Depression and Alcohol Dependence [Phase 3]
Phase 3 trial update for mecamylamine in depression with alcohol dependence; results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-04-18Clinical Trial Update: Using Mental Health Telemetry to Predict Relapse and Re-hospitalization in Mood Disorders [NA]
A clinical trial evaluating the use of mental health telemetry to predict relapse and re-hospitalization in mood disorders has completed.
-
FDA approval · 2016-04-15FDA Approved: TRIMIPRAMINE — Original Application (Breckenridge Pharmaceutical, Inc.)
The FDA approved Breckenridge Pharmaceutical's original application for trimipramine, a generic antidepressant.
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: Expressive Writing for Reducing Stress and Diabetic Symptoms in Diabetes Patients [Phase 2]
A Phase 2 trial evaluating expressive writing to reduce stress and diabetic symptoms in people with diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-14Clinical Trial Update: Enhancing Recovery in Coronary Heart Disease (ENRICHD) Patients [Phase 3]
Clinical trial update for the Phase 3 ENRICHD study assessing recovery in coronary heart disease; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-14Clinical Trial Update: Effectiveness of Depression Treatment Following Coronary Artery Bypass Surgery [NA]
A completed University of Pittsburgh trial evaluated the effectiveness of depression treatment following coronary artery bypass surgery, wit…
-
CLINICAL_TRIALS trial_result · 2016-04-13Clinical Trial Update: Holistic Approaches to Depression [Phase 2]
This update reports the completion of a Phase 2 clinical trial investigating holistic approaches to depression.
-
CLINICAL_TRIALS trial_result · 2016-04-13Clinical Trial Update: Low Field Magnetic Stimulation (LFMS) in Mood Disorders: 6 Treatments [Phase 1]
Phase 1 trial of Low Field Magnetic Stimulation (LFMS) for mood disorders has been suspended.
-
CLINICAL_TRIALS trial_result · 2016-04-13Clinical Trial Update: Cognitive Behaviour Therapy for Patients With IBS [NA]
A completed clinical trial evaluating cognitive-behavioral therapy for irritable bowel syndrome, including constipation and related symptoms…
-
CLINICAL_TRIALS trial_result · 2016-04-11Clinical Trial Update: Hepatitis C Translating Initiatives for Depression Into Effective Solutions [NA]
This VA-sponsored trial evaluating interventions for depression in people with Hepatitis C has completed, and its results were posted in Apr…
-
CLINICAL_TRIALS trial_result · 2016-04-11Clinical Trial Update: Paroxetine for the Treatment of Interferon Related Side Effects for Hepatitis C [NA]
Completed clinical trial assessing paroxetine for managing interferon-related side effects in hepatitis C, with depression noted as a coexis…